Clinical Trials Logo

Anxiety clinical trials

View clinical trials related to Anxiety.

Filter by:

NCT ID: NCT06062472 Completed - Depression Clinical Trials

Effect of Lactobacillus Paracasei PS23 on Improving Aging and Muscle Loss in the Elderly

Start date: August 8, 2023
Phase: N/A
Study type: Interventional

This study refers to the supplementation of PS23 in human experiments to help the elderly maintain muscle mass, delay muscle loss, promote physical activity, and delay the occurrence of disability and debilitation in elderly people.

NCT ID: NCT06061198 Completed - Anxiety Clinical Trials

Impact of Virtual Reality on Patient's Anxiety Who Underwent Surgery Uner Regional Anesthesia

VRanxiety
Start date: March 1, 2023
Phase: N/A
Study type: Interventional

this study was conducted in TAHER SFAR Hospital . it included 68 patients and it aims to evaluate the impact of virtual reality on patients undergoing upper limb surgery under regional anesthesia and evaluate the consumption of hypnotics during surgery , anxiety levels and patients satisfaction. this study contain 2 arms , each arm contain 34 patients . first arm received regional anesthesia and surgery under virtual reality using a VR gear . second arm received standard care

NCT ID: NCT06060860 Recruiting - Depression Clinical Trials

Comparing Cognitive-Behavioral Therapy Versus Mindfulness-Based Therapy for Autistic Adults

Start date: January 17, 2024
Phase: N/A
Study type: Interventional

Autistic adults are at a greater risk for mental health problems compared to the general population, with 50% meeting criteria for a co-occurring psychiatric condition. Depression and anxiety are the most common of these conditions among autistic adults, contributing to long-term detrimental effects on health, day-to-day functioning, and quality of life. This study will conduct the first large-scale head-to-head comparison of the two most widely studied mental health interventions for autistic adults: cognitive-behavioral therapy (CBT) and mindfulness-based therapy (MBT). Both interventions are well-established, empirically supported treatments for depression and anxiety in the general population, and both interventions have demonstrated efficacy among autistic adults. However, their comparative effectiveness and heterogeneity of treatment effects have not been established in autistic adults. Both interventions will be delivered by telehealth.

NCT ID: NCT06059794 Completed - Anxiety Clinical Trials

Anxiety in Relation to Nausea and Vomiting in Pregnancy

Start date: January 1, 2023
Phase:
Study type: Observational

The goal of this observational study is to learn more about the relation between anxiety (assessed by GAD-7 questionnaire) and the nausea and vomiting in pregnancy (objectively measured by PUQE score). Participants will answer 2 questionnaires: (GAD-7) for anxiety; and (PUQE score) for nausea and vomiting.

NCT ID: NCT06056609 Recruiting - Anxiety Clinical Trials

Mother and Baby Yoga Study - Early Postnatal Yoga and Mental Health

MABY
Start date: August 15, 2022
Phase: N/A
Study type: Interventional

Investigating the influence of an early postnatal mother and baby yoga programme on maternal mental health and relationship with baby: a randomised feasibility study. It is thought postnatal mother and baby yoga decreases levels of depression and anxiety and increases subjective experience of maternal-infant bonding. This project will provide the necessary data to determine whether a regular programme would be beneficial to mothers. The research study is an eight-week online programme incorporating gentle postnatal mother and baby yoga involving women 6-12 weeks following birth (at recruitment/study commencement). The outcome measures include mothers' feelings about their mental health and bond with their baby.

NCT ID: NCT06054243 Recruiting - Anxiety Clinical Trials

Efficacy of Group Cognitive Behavioural Therapy for Youth Anxiety and Insomnia

Start date: February 17, 2023
Phase: N/A
Study type: Interventional

Youth is an important transitional stage associated with dynamic changes in biological, cognitive, and psychological functioning, as well as a constellation of developmental and psychosocial challenges. In particular, anxiety disorders constitute the most common mental health problems in youth, with a prevalence rate up to 32%. Youth anxiety is associated with not only profound personal distress, but also considerable impairments in psychosocial functioning and an increased risk for developing other psychiatric comorbidities (e.g. depression, substance use). Meanwhile, sleep problems, particularly insomnia, are also common in the teen years, with a prevalence rate as high as 36%. Insomnia and anxiety are highly comorbid conditions, with increasing evidence suggesting their intricate, bidirectional relationship, such as a high level of anxiety symptoms found in youth with insomnia. However, optimal treatment strategies to manage the comorbidity of these two conditions remain uncertain. This study will test the efficacy of group-based cognitive behavioural therapy for insomnia (CBT-I) and cognitive behavioural therapy for anxiety (CBT-A) in reducing the severity of insomnia and anxiety symptoms in youth with comorbid insomnia and anxiety, as well as their effects on depressive symptoms, daytime functioning (e.g. sleepiness, fatigue), subjective and objective sleep measures.

NCT ID: NCT06053307 Not yet recruiting - Depression Clinical Trials

Treating Psychosocial Distress in Glaucoma

Start date: July 1, 2024
Phase: N/A
Study type: Interventional

In this study, using three phases, the investigators will use an iterative development approach to refine a behavioral intervention for managing concomitant psychosocial distress in glaucoma. Phase 1: The investigators will begin by developing a baseline intervention using strategies from Acceptance and Commitment Therapy (ACT), and delivered using a mobile application. Phase 2: The investigators will refine the baseline intervention for glaucoma patients using qualitative interviews conducted with primary open-angle glaucoma (POAG) patients with psychosocial distress (N=20), and health professionals (N=5). Phase 3: Finally, the investigators will measure acceptability and feasibility of the refined intervention through a single-armed pilot study (N=25). The investigators hypothesize that the refined intervention will yield an acceptable and feasible intervention in a POAG patient population, setting the stage for a future efficacy study.

NCT ID: NCT06051084 Enrolling by invitation - Anxiety Clinical Trials

Investigating How the Brain Processes Different Experiences

Start date: October 5, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test the efficacy of an app-based program in reducing anxiety and exploring associated changes in brain activity.

NCT ID: NCT06047704 Completed - Pain Clinical Trials

The Effect of State and Trait Anxiety on Pain-pressure Threshold

Start date: July 28, 2023
Phase:
Study type: Observational

The purpose of this research is to find out if different types of anxiety impact the sensation of how sensitive various muscles are to the application of pressure. This information can help researchers and healthcare providers better understand how people feel pain differently based on emotional factors This study is designed to study people who can be expected to have normal pain sensation processing

NCT ID: NCT06046586 Not yet recruiting - Depression Clinical Trials

Internet-Delivered Psychological Treatment for Cancer Survivors

IN-FACT-1
Start date: January 1, 2025
Phase: N/A
Study type: Interventional

Negative psychological effects of cancer are common, but cancer survivors are rarely offered structured psychological treatment. Internet-delivered treatments have shown some promise, but specific treatment components have not been empirically evaluated which means that it is not clear which therapies that should be prioritized. In this randomized factorial trial at Karolinska Institutet, Stockholm, Sweden, 400 cancer survivors with psychiatric symptoms are enrolled in variations on a 10-week therapist-guided online psychological treatment intended to address the negative psychological long-term effects of cancer. The aim is to determine the contribution of treatment components to the overall effect.